• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β1 整联蛋白单克隆抗体治疗改善脑海绵状血管畸形。

β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.

机构信息

Department of Medicine, University of California San Diego, La Jolla, California, USA.

Department of Neurological Surgery, University of Chicago, Chicago, Illinois, USA.

出版信息

FASEB J. 2022 Dec;36(12):e22629. doi: 10.1096/fj.202200907RR.

DOI:10.1096/fj.202200907RR
PMID:36349990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9674378/
Abstract

β1 integrins are important in blood vessel formation and function, finely tuning the adhesion of endothelial cells to each other and to the extracellular matrix. The role of integrins in the vascular disease, cerebral cavernous malformation (CCM) has yet to be explored in vivo. Endothelial loss of the gene KRIT1 leads to brain microvascular defects, resulting in debilitating and often fatal consequences. We tested administration of a monoclonal antibody that enforces the active β1 integrin conformation, (clone 9EG7), on a murine neonatal CCM mouse model, Krit1 ;Pdgfb-iCreERT2 (Krit1 ), and on KRIT1-silenced human umbilical vein endothelial cells (HUVECs). In addition, endothelial deletion of the master regulator of integrin activation, Talin 1 (Tln1), in Krit1 mice was performed to assess the effect of completely blocking endothelial integrin activation on CCM. Treatment with 9EG7 reduced lesion burden in the Krit1 model and was accompanied by a strong reduction in the phosphorylation of the ROCK substrate, myosin light chain (pMLC), in both retina and brain endothelial cells. Treatment of KRIT1-silenced HUVECs with 9EG7 in vitro stabilized cell-cell junctions. Overnight treatment of HUVECs with 9EG7 resulted in significantly reduced total surface expression of β1 integrin, which was associated with reduced pMLC levels, supporting our in vivo findings. Genetic blockade of integrin activation by Tln1 enhanced bleeding and did not reduce CCM lesion burden in Krit1 mice. In sum, targeting β1 integrin with an activated-specific antibody reduces acute murine CCM lesion development, which we found to be associated with suppression of endothelial ROCK activity.

摘要

β1 整合素在血管形成和功能中起着重要作用,精细调节内皮细胞彼此以及与细胞外基质的黏附。整合素在血管疾病、脑海绵状血管畸形(CCM)中的作用尚未在体内进行探索。内皮细胞 KRIT1 基因的缺失导致脑微血管缺陷,导致衰弱甚至常常致命的后果。我们在 Krit1 ;Pdgfb-iCreERT2(Krit1)新生鼠 CCM 模型和 KRIT1 沉默的人脐静脉内皮细胞(HUVEC)上测试了一种单克隆抗体(克隆 9EG7)的给药,该抗体强制激活β1 整合素构象。此外,还在 Krit1 小鼠中进行了内皮细胞整联蛋白激活的主调控因子 Talin 1(Tln1)的缺失,以评估完全阻断内皮整联蛋白激活对 CCM 的影响。9EG7 治疗可降低 Krit1 模型中的病变负担,并伴有视网膜和脑内皮细胞中 ROCK 底物肌球蛋白轻链(pMLC)的磷酸化强烈减少。9EG7 在体外处理 KRIT1 沉默的 HUVECs 可稳定细胞-细胞连接。HUVECs overnight 用 9EG7 处理可导致β1 整联蛋白总表面表达显著减少,这与 pMLC 水平降低相关,支持我们的体内发现。Tln1 对整合素激活的遗传阻断增强了出血,并且没有减少 Krit1 小鼠中的 CCM 病变负担。总之,用激活特异性抗体靶向β1 整合素可减少急性小鼠 CCM 病变的发展,我们发现这与抑制内皮 ROCK 活性有关。

相似文献

1
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.β1 整联蛋白单克隆抗体治疗改善脑海绵状血管畸形。
FASEB J. 2022 Dec;36(12):e22629. doi: 10.1096/fj.202200907RR.
2
Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.Krit1与Icap1α之间的相互作用表明,在脑海绵状血管畸形的发病机制中,整合素β1介导的血管生成受到了干扰。
Hum Mol Genet. 2001 Dec 1;10(25):2953-60. doi: 10.1093/hmg/10.25.2953.
3
KRIT1-mediated regulation of neutrophil adhesion and motility.KRIT1 介导的中性粒细胞黏附与迁移的调控。
FEBS J. 2023 Feb;290(4):1078-1095. doi: 10.1111/febs.16627. Epub 2022 Sep 20.
4
CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling.CCM1-ICAP-1 复合物控制 β1 整合素依赖性内皮细胞收缩性和纤维连接蛋白重塑。
J Cell Biol. 2013 Aug 5;202(3):545-61. doi: 10.1083/jcb.201303044.
5
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.脑内海绵状血管畸形在人类和小鼠中形成一个抗凝血的血管区域。
Blood. 2019 Jan 17;133(3):193-204. doi: 10.1182/blood-2018-06-856062. Epub 2018 Nov 15.
6
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.脑内海绵状血管畸形蛋白抑制 Rho 激酶以稳定血管完整性。
J Exp Med. 2010 Apr 12;207(4):881-96. doi: 10.1084/jem.20091258. Epub 2010 Mar 22.
7
Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins.CCM 蛋白对 β1 整合素-Klf2 介导的血管生成的调控。
Dev Cell. 2015 Jan 26;32(2):181-90. doi: 10.1016/j.devcel.2014.12.016.
8
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.KRIT1:氧化还原信号与脑动静脉畸形病发病机制之间的繁忙十字路口的交通管理员。
Antioxid Redox Signal. 2023 Mar;38(7-9):496-528. doi: 10.1089/ars.2021.0263. Epub 2022 Nov 1.
9
Immunofluorescence of Cell-Cell and Cell-Extracellular Matrix Adhesive Defects in In Vitro Endothelial CCM Model: Juxtacrine Role of Mutant Extracellular Matrix on Wild-Type Endothelial Cells.体外内皮细胞慢性细胞力学环境模型中细胞间及细胞与细胞外基质黏附缺陷的免疫荧光:突变细胞外基质对野生型内皮细胞的旁分泌作用
Methods Mol Biol. 2020;2152:401-416. doi: 10.1007/978-1-0716-0640-7_29.
10
Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.整合素胞质结构域相关蛋白-1(ICAP1)的核定位影响β1整合素激活并将Krev/相互作用捕获蛋白-1(KRIT1)招募至细胞核。
J Biol Chem. 2017 Feb 3;292(5):1884-1898. doi: 10.1074/jbc.M116.762393. Epub 2016 Dec 21.

引用本文的文献

1
Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice.整合素介导的mTOR信号通路驱动低表达原纤蛋白-1小鼠的转化生长因子-β过度活化和黏液瘤样二尖瓣退变。
J Clin Invest. 2025 May 20;135(14). doi: 10.1172/JCI183558. eCollection 2025 Jul 15.
2
Hydrogels with tunable mechanical plasticity regulate endothelial cell outgrowth in vasculogenesis and angiogenesis.具有可调节机械塑性的水凝胶可调节血管生成和血管生成中内皮细胞的生长。
Nat Commun. 2023 Dec 14;14(1):8307. doi: 10.1038/s41467-023-43768-0.
3
A year in review: brain barriers and brain fluids research in 2022.年度回顾:2022 年的脑屏障和脑液研究。
Fluids Barriers CNS. 2023 Apr 21;20(1):30. doi: 10.1186/s12987-023-00429-0.